Relay Therapeutics, Inc. (RLAY)
13.85
+0.19
(+1.39%)
USD |
NASDAQ |
Jun 09, 14:39
Relay Therapeutics SG&A Expense (Quarterly) : 11.03M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 15.23M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Exelixis, Inc. | 139.60M |
| Insmed, Inc. | 247.26M |
| United Therapeutics Corp. | 156.60M |